` SYA (Synlab AG) vs DAX Index Comparison - Alpha Spread

SYA
vs
D
DAX Index

Over the past 12 months, SYA has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +9% growth.

Stocks Performance
SYA vs DAX Index

Loading
SYA
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SYA vs DAX Index

Loading
SYA
DAX Index
Difference
www.alphaspread.com

Performance By Year
SYA vs DAX Index

Loading
SYA
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Synlab AG vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Synlab AG
Glance View

Market Cap
2.2B EUR
Industry
Health Care

Synlab AG, a leading provider in the medical diagnostics sector, stands as a testament to the intersection of science and business acumen in the modern healthcare landscape. Founded as a consolidation of various laboratories, Synlab has expanded its reach across Europe and beyond, establishing itself as a pioneer in the field of laboratory services. Its offerings span a broad spectrum of diagnostic tests, from routine blood work to advanced genetic testing, serving hospitals, clinics, and private practitioners. Synlab’s laboratories operate with cutting-edge technology, ensuring precision and reliability, which are critical to delivering actionable insights for patient care. This expansive network of labs not only caters to everyday diagnostic needs but is also heavily engaged in specialized testing services, underpinning its reputation as a trusted partner in the healthcare industry. The company’s revenue model is intricately linked to the volume and complexity of tests conducted, as well as contractual arrangements with national health services and insurance companies. By leveraging economies of scale and a highly integrated IT system, Synlab improves efficiency and reduces costs, maximizing its profitability. Additionally, the company strategically reinvests in research and development to stay at the forefront of medical innovation, ensuring it remains a step ahead in the competitive diagnostics market. While regulatory environments and healthcare policies can pose challenges, Synlab’s broad geographical footprint and comprehensive service portfolio provide a buffer against such fluctuations. Through this strategic balance of expansion, innovation, and operational excellence, Synlab AG continues to drive its growth and secure its position as a leader in the global diagnostics landscape.

SYA Intrinsic Value
Not Available
Back to Top